PsychPlus

PsychPlus in Seattle, Washington offers Spravato (esketamine) for adults with treatment-resistant depression, administered in-office under clinical supervision. This FDA-approved nasal spray works through a different mechanism than traditional antidepressants, providing an option for patients who have not responded adequately to other treatments.

The practice emphasizes accessible, evidence-based psychiatric care with a personalized approach to medication management and a thorough upfront evaluation to match each patient with the right treatment.

Alongside Spravato, the Seattle clinic provides psychiatry, therapy, and medication management, with both in-person and virtual appointments available. Walk-ins are welcome Monday through Friday, and PsychPlus is in-network with most insurance, including Medicare and Medicaid, often with low or no copay.